All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
President’s Outlook 2018
By Mark Land, AAHP President March 1, 2018 Our association concluded one of its most successful years in 2017. The momentum created last year is...
The German Homeopathic Pharmacopeia
By Eric Foxman, AAHP secretary February 1, 2018 A quick look at its history, purpose and contents, as well as the potential for adulteration and...
United States Food and Drug Administration – Good Guidance Practices
By Mark Land, AAHP president February 1, 2018 The Food and Drug Administration (FDA) amended its administrative regulations to codify its policies and procedures for...
Prominence in Advertising and Labeling
By Mark Land, AAHP president February 1, 2018 A search under the term “prominence” yields 43 citations within Title 21 of the U.S. Code of...
Testing the New AAHP Disclaimer for Effectiveness
By Jeremy Kees, PhD, Professor, Marketing & Business Law and Faculty Director, Villanova University February 1, 2018 The American Association of Homeopathic Pharmacists (AAHP) enlisted...
AAHP Shares FDA’s Commitment to Protecting Public Health
December 19, 2017 In response to the U.S. Food and Drug Administration's (FDA) draft guidance on homeopathic drug products released on Monday, December 18, 2017,...
Arnica montana: A Clinical Snapshot
By Todd Hoover, MD December 11, 2017 Arnica montana has been used for centuries as a phytomedicine for its analgesic and anti-inflammatory properties. Commonly known...
